Ibandronate Sodium CAS 138926-19-9

Dayang Chem (Hangzhou) Co., Ltd huwa wieħed mill-manifatturi u fornituri ewlenin ta 'ibandronate sodium cas 138926-19-9 fiċ-Ċina, speċjalizzati fil-forniment ta' kimiċi personalizzati ta 'kwalità għolja. Merħba għall-ingrossa bl-ingrossa ibandronate sodium cas 138926-19-9 magħmul fiċ-Ċina hawn u ikseb pricelist mill-fabbrika tagħna. Servizz tajjeb u prezz raġonevoli huma disponibbli.

Introduzzjoni tal-Prodott:

1.     Speċifikazzjoni

L-aħħar speċifikazzjonijiet u COA jintbagħtu fuq talba.

2.     Ippakkjar u tbaħħir

3.     Applikazzjonijiet

Ibandronate huwa nitroġenu qawwi ħafna -bifosfonat li fih użat għat-trattament tal-osteoporożi. Mira: OħrajnIbandronate (1.25-2 M) inaqqas b'mod sinifikanti t-tkabbir taċ-ċelluli endoteljali, filwaqt li ibandronate (2 M) inaqqas ukoll b'mod sinifikanti l-formazzjoni ta 'tubi simili kapillari u jżid l-apoplitożi taċ-ċelluli endothelial. Ibandronate (< 100 M) dose-dependently increases VEGF expression in endothelial cells . Ibandronate (< 100 M) inhibits growth of both prostate cancer cell lines (LNCaP and PC-3) in a dose dependent manner .Ibandronate administered either daily (2.5 mg) or intermittently (20 mg every other day for 12 doses every 3 months) significantly reduces the risk of new morphometric vertebral fractures by 62% and 50% (p = 0.0006), respectively, in osteoporotic women after 3 years' treatment. Ibandronate administered either daily (2.5 mg) or intermittently (20 mg every other day for 12 doses every 3 months) significantly and progressively increases BMD of lumbar spine by 6.5% and 5.7%, respectively, in osteoporotic women after 3 years' treatment . Ibandronate (< 125 mg/kg s.c.) results in a dose dependent increase in bone mineral density (BMD), trabecular bone volume and trabecular number, load to failure (Fmax), and yield load in long bones and vertebrae in ovariectomized rats, and increased trabecular separation in ovariectomized rats is fully prevented by all doses .

4.     Spettru

5.     Artikoli Relatati

It-tags Popolari: ibandronate sodium cas 138926-19-9, iċ-Ċina ibandronate sodium cas 138926-19-9 manifatturi, fornituri, fabbrika